Straumann

Basel, Switzerlandwww.straumann.com/
Invested through
  • Triodos Pioneer Impact Fund
Asset ClassesListed equity
Impact strategyImpact Equities and Bonds
Bloomberg tickerSTMN SW
ISIN codeCH0012280076
Industry groupHealth Care Equipment & Services
Aligned with SDGs
  • Good health and well-being

Straumann Group is a global leader in aesthetic dentistry. The company develops, manufactures, and supplies dental implant systems, biomaterials, computer-aided design and manufacturing prosthetics, digital equipment, software, clear aligner systems (orthodontics) and various materials for dental applications. The company’s client base consists of general dentists, followed by specialists, dental technicians/laboratories, and corporate customers such as distributors, hospitals, universities, and dental service organizations. Straumann's reporting segments correspond to the geographic regions where the company is active: Europe, Middle East & Africa (43% of sales in FY20), North America (30% of sales), Asia Pacific (20% of sales) and Latin America (6% of sales). Straumann began as a research institute in 1954 and is now a global holding company with a staff of 7,340 people, headquartered in Basel, Switzerland, and active in more than 100 countries around the world.

Investment rationale

With its offering of dental implants and related adjacent products, Straumann enhances the well-being and quality of life of people around the world. In recent years the company has expanded to regions with a greater presence of developing countries, and at the same time it has broadened its offering with less expensive products. These geographic and price range expansions increase the accessibility to its products for people with less resources, which reinforces the positive health impact that the company's products deliver.